ATE29875T1 - Allylamin-mao-inhibitoren. - Google Patents

Allylamin-mao-inhibitoren.

Info

Publication number
ATE29875T1
ATE29875T1 AT82400991T AT82400991T ATE29875T1 AT E29875 T1 ATE29875 T1 AT E29875T1 AT 82400991 T AT82400991 T AT 82400991T AT 82400991 T AT82400991 T AT 82400991T AT E29875 T1 ATE29875 T1 AT E29875T1
Authority
AT
Austria
Prior art keywords
sub
integer
hydrogen
formula
phenyl
Prior art date
Application number
AT82400991T
Other languages
German (de)
English (en)
Inventor
Philippe Bey
Original Assignee
Merrell Dow France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow France filed Critical Merrell Dow France
Application granted granted Critical
Publication of ATE29875T1 publication Critical patent/ATE29875T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/62—Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/46—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
    • C07C33/48—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts with unsaturation outside the aromatic rings
    • C07C33/483—Monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/46—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
    • C07C33/48—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts with unsaturation outside the aromatic rings
    • C07C33/486—Polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
  • Treatment Of Sludge (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT82400991T 1981-06-01 1982-05-27 Allylamin-mao-inhibitoren. ATE29875T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/268,555 US4454158A (en) 1981-06-01 1981-06-01 Allyl amine MAO inhibitors
EP82400991A EP0067105B1 (en) 1981-06-01 1982-05-27 Allyl amine mao inhibitors

Publications (1)

Publication Number Publication Date
ATE29875T1 true ATE29875T1 (de) 1987-10-15

Family

ID=23023513

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82400991T ATE29875T1 (de) 1981-06-01 1982-05-27 Allylamin-mao-inhibitoren.

Country Status (18)

Country Link
US (1) US4454158A (esLanguage)
EP (1) EP0067105B1 (esLanguage)
JP (1) JPS5823649A (esLanguage)
KR (1) KR890002756B1 (esLanguage)
AT (1) ATE29875T1 (esLanguage)
AU (2) AU550607B2 (esLanguage)
CA (2) CA1187500A (esLanguage)
DE (1) DE3277371D1 (esLanguage)
DK (1) DK244282A (esLanguage)
ES (4) ES8402810A1 (esLanguage)
GB (2) GB2100255B (esLanguage)
GR (1) GR78033B (esLanguage)
IE (1) IE53456B1 (esLanguage)
IL (2) IL65808A (esLanguage)
MX (1) MX9202950A (esLanguage)
NO (1) NO152837C (esLanguage)
NZ (1) NZ200644A (esLanguage)
ZA (1) ZA823633B (esLanguage)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699928A (en) * 1984-07-13 1987-10-13 Merrell Dow Pharmaceuticals Inc. Fluoroallylamine derivatives
US4703058A (en) * 1984-12-31 1987-10-27 Merrell Dow Pharmaceuticals Inc. β-methylene furanethanamines and use as anti-hypertensive agents
NZ214697A (en) * 1984-12-31 1988-10-28 Merrell Dow Pharma B-methylene-2- and 3-furanethanamine and pharmaceutical compositions
NZ214698A (en) * 1984-12-31 1988-08-30 Merrell Dow Pharma Thiophene derivatives and pharmaceutical compositions containing such
JPH0660132B2 (ja) * 1985-12-05 1994-08-10 メレルダウフア−マス−テイカルズ インコ−ポレ−テツド 非芳香族フルオロアリルアミンｍａｏ阻害剤
US4650907A (en) * 1985-12-05 1987-03-17 Merrell Dow Pharmaceuticals Inc. Nonaromatic fluoroallylamine MAO inhibitors
US4822812A (en) * 1987-05-21 1989-04-18 Merrell Dow Pharmaceuticals Inc. β-(Fluoromethylene)-5-hydroxytryptophan and derivatives and their use as prodrugs for MAO inhibition
AR243493A1 (es) * 1987-06-16 1993-08-31 Merrell Dow Pharma Procedimiento para preparar (e)-2-(p-fluorfenetil)-3-fluoralilamina y sus sales farmaceuticamente aceptables, util como inhibidor de mao-b irreversible y activado por enzimas.
US4943593A (en) * 1988-02-25 1990-07-24 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5182297A (en) * 1988-02-25 1993-01-26 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US4965288A (en) * 1988-02-25 1990-10-23 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
AU618076B2 (en) * 1988-02-25 1991-12-12 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyloxidase
US5059714A (en) * 1988-02-25 1991-10-22 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5252608A (en) * 1988-02-25 1993-10-12 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5120764A (en) * 1988-11-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US4981868A (en) * 1989-07-25 1991-01-01 Merrell Dow Pharmaceutical Pharmaceutically active 3-heteroaryl-2-fluoro-1-olefins
JP3273141B2 (ja) * 1995-03-02 2002-04-08 アール． ピー． シェーラー リミテッド モノアミンオキシダーゼｂインヒビターからなる医薬組成物
WO2007120528A2 (en) * 2006-03-31 2007-10-25 La Jolla Pharmaceutical Company Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
EP2046794A1 (de) * 2006-07-13 2009-04-15 Basf Se Fungizide azolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel
WO2009055002A1 (en) * 2007-10-24 2009-04-30 La Jolla Pharmaceutical Company Combined inhibitors of cyclooxygenase and semicarbazide-sensitive amine oxidase (ssao) (vascular adhesion protein, vap-1)
AU2008327615B2 (en) 2007-11-21 2014-08-21 Pharmaxis Ltd. Haloallylamine inhibitors of SSAO/VAP-1 and uses therefor
US9302986B2 (en) 2012-05-02 2016-04-05 Boehringer Ingelheim International Gmbh Substituted 3-haloallylamine inhibitors of ASSAO and uses thereof
WO2015087094A1 (en) * 2013-12-10 2015-06-18 Semmelweis Egyetem New arylalkenylpropargylamine derivatives exhibiting neuroprotective action for the treatment of neurodegenerative diseases
TW202019877A (zh) 2018-08-03 2020-06-01 澳大利亞商法瑪西斯有限公司 離胺醯氧化酶之鹵化烯丙胺碸衍生物抑制劑及其用途
US12233056B2 (en) 2022-04-06 2025-02-25 Syntara Limited Lysyl oxidase inhibitors for treating myeloid malignancies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2343038A1 (de) * 1973-08-25 1975-03-06 Hoechst Ag 2,3-diaryl-3-halogenallylamine und verfahren zu ihrer herstellung
SE7809127L (sv) * 1978-08-30 1980-03-01 Claesson Alf Allenaminer

Also Published As

Publication number Publication date
IL65808A (en) 1986-12-31
ES523873A0 (es) 1985-10-01
EP0067105A3 (en) 1984-02-22
EP0067105B1 (en) 1987-09-23
ZA823633B (en) 1983-03-30
NO152837B (no) 1985-08-19
US4454158B1 (esLanguage) 1992-12-22
KR890002756B1 (ko) 1989-07-27
AU576281B2 (en) 1988-08-18
GB2100255A (en) 1982-12-22
US4454158A (en) 1984-06-12
DE3277371D1 (en) 1987-10-29
AU8423882A (en) 1983-02-03
AU550607B2 (en) 1986-03-27
NZ200644A (en) 1986-06-11
DK244282A (da) 1982-12-02
NO821799L (no) 1982-12-02
JPS5823649A (ja) 1983-02-12
ES523874A0 (es) 1985-04-16
ES512699A0 (es) 1984-03-01
ES8503638A1 (es) 1985-04-16
GB2100255B (en) 1985-10-23
CA1187500A (en) 1985-05-21
ES8507461A1 (es) 1985-10-01
GR78033B (esLanguage) 1984-09-26
ES8402810A1 (es) 1984-03-01
IL75829A0 (en) 1985-11-29
MX9202950A (es) 1992-07-01
GB8428858D0 (en) 1984-12-27
GB2152039B (en) 1986-04-30
AU5180586A (en) 1986-06-12
JPH0422898B2 (esLanguage) 1992-04-20
NO152837C (no) 1985-11-27
GB2152039A (en) 1985-07-31
IE53456B1 (en) 1988-11-23
CA1204759A (en) 1986-05-20
IE821246L (en) 1982-12-01
KR830010044A (ko) 1983-12-24
ES523875A0 (es) 1985-04-16
IL65808A0 (en) 1982-08-31
ES8503639A1 (es) 1985-04-16
EP0067105A2 (en) 1982-12-15

Similar Documents

Publication Publication Date Title
US4454158B1 (esLanguage)
KR900007406A (ko) 리실 옥시마제의 억제제
NO20006378L (no) Epotilonderivater samt deres syntese og anvendelse
PH17786A (en) New methyl substituted 4-methoxy-pyridine-n-oxides to be used as intermediate in the preparation of the new intermediate
NO921719L (no) Fosfono/biaryl-substituerte dipeptidderivater
ATE94065T1 (de) Diazepine enthaltende pharmazeutische zusammensetzungen mit plaettchen aktivierender faktor (paf)-antagonistischer wirkung.
YU64092A (sh) Fluoralkoksibenzamino derivati heterocikličnih jedinjenja koja sadrže azot
LU90902I2 (fr) Eletriptan et ses sels pharmaceutiquement acceptables y compris le sel d'hydrobromure
CO5090848A1 (es) Compuestos de benceno sustituidos, procedimientos para su preparacion, y composiciones herbicidas y de foliantes que los contienen
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
FI934680A0 (fi) Arylmorfolin, framstaellning och anvaending
EA199600007A3 (ru) Новые трициклические производные, способ их получения, способы получения оптически активных или рацемических колхицина и тиоколхицина, их аналогов или производных с использованием трициклических соединений и промежуточные продукты синтеза
KR890012641A (ko) 리실 옥시다제의 억제제
MY103360A (en) Heterocyclic neophane analogs, processes for their preparation and their use as pest- combating agents
ATE80153T1 (de) Muscarin-rezeptor-antagonisten.
FI955680A0 (fi) Psoraleenijohdannaiset, niiden valmistus ja käyttö
MY104048A (en) New allylaminoethylazoles.
JPS51143691A (en) New derivatives of 1,4-diaza-5-oxo- cycloheptanes